To the best of our knowledge, no study has examined SLC22A8 methylation and the extent of SLC22A8 enrichment in immune infiltrating cells as prognostic biomarkers in patients with renal clear cell carcinoma. This evidence concerns the gene SLC22A8 and clear cell renal carcinoma.